There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open3,322.7
High3,360
Low3,312
Prev. Close3,322.7
Avg. Traded Price3,340.13
Volume8,39,808
MARKET DEPTH
Total bid33,162.00
Total ask36,475.00
Orders
Qty
Bid
2
5
3326.6
2
4
3326.5
4
10
3326.4
1
3
3326.2
3
11
3326.1
Ask
Qty
Orders
3328
1
1
3328.4
1
1
3328.5
1
3
3328.7
2
6
3328.8
1
6
HIGH/LOW
1d
1w
1m
3m
52w
LOW/HIGH
₹3,312.0028 minutes ago
₹3,360.003 hours ago
LOWER/UPPER CIRCUITS
₹2,990.50
₹3,654.90
Torrent Pharmaceuticals Ltd Stock performance
KEY OBSERVATIONS
positive
negative
neutral
Annual Revenue,rose 11.59%, in the last year to ₹10,785.75 Cr. Its sector's average revenue growth for the last fiscal year was 12.27%.
Annual Net Profit,rose 33.02% in the last year to ₹1,656.38 Cr. Its sector's average net profit growth for the last fiscal year was 29.44%.
Return on Equity(ROE),for the last financial year was 24.15%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
View more
LONG-TERM PRICE ANALYSIS
Stock return5Y CAGR : 21.68%
Net profit growth 5Y CAGR : 30.59%
STOCK RETURNS
Versus Nifty 50
1 w
-0.48%
vs
-0.36%
1 mth
+0.34%
vs
+2.21%
3 mth
-2.29%
vs
+4.71%
6 mth
-2.35%
vs
-1.23%
1 yr
+20.52%
vs
+6.16%
3 yr
+132.59%
vs
+39.4%
5 yr
+161.13%
vs
+156.26%
ANALYST RATING
Aggregated across 100 coverages
Buy
Hold
Sell
60%
40%
0%
Powered by Trendlyne.
Torrent Pharmaceuticals Ltd Top mutual funds holding
Torrent Pharmaceuticals Limited has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.
Grow your wealth with more research recommendations